US Patent Issued to SyntheX on March 31 for "Compounds for selective disruption of protein-protein interactions" (California Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,126, issued on March 31, was assigned to SyntheX Inc. (San Francisco).

"Compounds for selective disruption of protein-protein interactions" was invented by Charly Chahwan (San Francisco) and Maria Soloveychik (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods to treat conditions, including cancer, using compounds that can target resistant cancer cells. The compounds can be used to sensitize resistant cancer cells or decrease the proliferation of cells. The compounds can target proteins in the DNA damage repair pathway leading to a decrease in DNA damage repair and cell death."

The patent was filed...